Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Prostatic Neoplasms 15Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Glioblastoma 7Esophageal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Burkitt Lymphoma 7Uterine Cervical Neoplasms 6Rhabdomyosarcoma 6Squamous Cell Carcinoma of Head and Neck 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Sarcoma 3Rhabdomyosarcoma, Embryonal 3Rectal Neoplasms 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Follicular 3Lung Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Adenocarcinoma of Lung 3Vaginal Neoplasms 2Rhabdomyosarcoma, Alveolar 2Prostate Adenocarcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2

Interventions

Cisplatin 51Gemcitabine 28Radiotherapy, Intensity-Modulated 26Capecitabine 19Docetaxel 16toripalimab 12Fluorouracil 11Radiotherapy 9Drug Therapy 8nedaplatin 6camrelizumab 6Induction Chemotherapy 5spartalizumab 4nimotuzumab 4Neoadjuvant Therapy 4Carboplatin 4tislelizumab 3Immune Checkpoint Inhibitors 3Chemoradiotherapy 3sintilimab 2cisplatin-guanosine adduct 2apatinib 2SSRP1 protein, human 2Radiation 2Injections 2Endostatins 2CF regimen 2streptococcal preparation 722 1penpulimab 1lobaplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Nasopharyngeal Carcinoma × Radiation × Clear all
NCT07540390 2026-04-22

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

Sun Yat-sen University

Phase 3 Not yet recruiting
442 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03529279 2018-05-18

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

Sun Yat-sen University

Phase 3 Not yet recruiting
1,324 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡